ABVC Provides Oncology Pipeline Updates
22 août 2022 08h30 HE
|
ABVC BioPharma, Inc.
Phase II Clinical Trial for Pancreatic Cancer Planned for Q2 2023 FREMONT, CA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage...